State Board of Administration of Florida Retirement System’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,801
| Closed | -$105K | – | 2292 |
|
|
2024
Q1 | $105K | Sell |
1,801
-160
| -8% | -$2.81K | ﹤0.01% | 2053 |
|
|
2023
Q4 | $25.4K | Buy |
+1,961
| New | +$26.4K | ﹤0.01% | 2392 |
|
|
2023
Q3 | – | Sell |
-2,144
| Closed | -$57.6K | – | 2379 |
|
|
2023
Q2 | $57.6K | Buy |
2,144
+343
| +19% | +$14.8K | ﹤0.01% | 2375 |
|
|
2023
Q1 | $105K | Hold |
1,801
| – | – | ﹤0.01% | 2137 |
|
|
2022
Q4 | $91.9K | Sell |
1,801
-1,737
| -49% | -$120K | ﹤0.01% | 2217 |
|
|
2022
Q3 | $290K | Hold |
3,538
| – | – | ﹤0.01% | 1883 |
|
|
2022
Q2 | $239K | Hold |
3,538
| – | – | ﹤0.01% | 2041 |
|
|
2022
Q1 | $391K | Hold |
3,538
| – | – | ﹤0.01% | 1901 |
|
|
2021
Q4 | $341K | Sell |
3,538
-1
| -0% | -$100 | ﹤0.01% | 2003 |
|
|
2021
Q3 | $309K | Buy |
3,539
+1,328
| +60% | +$138K | ﹤0.01% | 2088 |
|
|
2021
Q2 | $342K | Buy |
2,211
+455
| +26% | +$66K | ﹤0.01% | 2074 |
|
|
2021
Q1 | $277K | Hold |
1,756
| – | – | ﹤0.01% | 2081 |
|
|
2020
Q4 | $408K | Hold |
1,756
| – | – | ﹤0.01% | 1880 |
|
|
2020
Q3 | $385K | Hold |
1,756
| – | – | ﹤0.01% | 1761 |
|
|
2020
Q2 | $499K | Buy |
1,756
+350
| +25% | +$104K | ﹤0.01% | 1629 |
|
|
2020
Q1 | $405K | Buy |
1,406
+218
| +18% | +$60.1K | ﹤0.01% | 1609 |
|
|
2019
Q4 | $342K | Buy |
1,188
+88
| +8% | +$19.1K | ﹤0.01% | 1896 |
|
|
2019
Q3 | $159K | Hold |
1,100
| – | – | ﹤0.01% | 2143 |
|
|
2019
Q2 | $99K | Hold |
1,100
| – | – | ﹤0.01% | 2251 |
|
|
2019
Q1 | $96K | Hold |
1,100
| – | – | ﹤0.01% | 2262 |
|
|
2018
Q4 | $155K | Buy |
1,100
+10
| +0.9% | +$1.69K | ﹤0.01% | 2188 |
|
|
2018
Q3 | $278K | Hold |
1,090
| – | – | ﹤0.01% | 2109 |
|
|
2018
Q2 | $278K | Buy |
1,090
+53
| +5% | +$13.1K | ﹤0.01% | 2140 |
|
|
2018
Q1 | $209K | Buy |
1,037
+53
| +5% | +$10.6K | ﹤0.01% | 2223 |
|
|
2017
Q4 | $142K | Hold |
984
| – | – | ﹤0.01% | 2321 |
|
|
2017
Q3 | $162K | Hold |
984
| – | – | ﹤0.01% | 2319 |
|
|
2017
Q2 | $134K | Buy |
984
+150
| +18% | +$22.2K | ﹤0.01% | 2351 |
|
|
2017
Q1 | $161K | Hold |
834
| – | – | ﹤0.01% | 2253 |
|
|
2016
Q4 | $118K | Hold |
834
| – | – | ﹤0.01% | 2310 |
|
|
2016
Q3 | $122K | Hold |
834
| – | – | ﹤0.01% | 2318 |
|
|
2016
Q2 | $84K | Buy |
834
+11
| +1% | +$1.43K | ﹤0.01% | 2325 |
|
|
2016
Q1 | $110K | Hold |
823
| – | – | ﹤0.01% | 2325 |
|
|
2015
Q4 | $163K | Buy |
823
+9
| +1% | +$1.95K | ﹤0.01% | 2313 |
|
|
2015
Q3 | $129K | Buy |
814
+40
| +5% | +$10.7K | ﹤0.01% | 2345 |
|
|
2015
Q2 | $316K | Buy |
774
+241
| +45% | +$104K | ﹤0.01% | 2158 |
|
|
2015
Q1 | $245K | Buy |
533
+62
| +13% | +$26.7K | ﹤0.01% | 2254 |
|
|
2014
Q4 | $264K | Buy |
471
+9
| +2% | +$5.11K | ﹤0.01% | 2267 |
|
|
2014
Q3 | $242K | Buy |
+462
| New | +$261K | ﹤0.01% | 2307 |
|
Other funds holding KPTI
PAI
EP
State Board of Administration of Florida Retirement System's KPTI Position: Q2 2024 in Review
State Board of Administration of Florida Retirement System sold out of Karyopharm Therapeutics (KPTI) in Q2 2024, closing a stake of 1,801 shares — an estimated $105K sold.
State Board of Administration of Florida Retirement System first reported a position in KPTI in Q3 2014 and held it in 38 quarters. The position peaked at $499K in Q2 2020. 114 funds tracked by Wall St. Rank hold KPTI as of Q2 2024.
- State Board of Administration of Florida Retirement System reported no remaining Karyopharm Therapeutics position as of Q2 2024 after selling out during the quarter.
- State Board of Administration of Florida Retirement System sold 1,801 Karyopharm Therapeutics shares in Q2 2024, an estimated $105K.
- State Board of Administration of Florida Retirement System first reported a position in Karyopharm Therapeutics in Q3 2014 and held it in 38 quarters.
- State Board of Administration of Florida Retirement System's Karyopharm Therapeutics position peaked at $499K in Q2 2020.
- 114 funds tracked by Wall St. Rank held Karyopharm Therapeutics as of Q2 2024.
Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2024, filed 8 Aug 2024.